Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...

A Useful Diagnostic Tool in Nasal Allergen Provocation Testing,” published in the May 2025 issue of Annals of Allergy, Asthma ...

Today's consumers have high expectations when it comes to their snacks. They want protein that powers them throughout the day ...

Republic Business Credit has supplied a leading medical supply manufacturer with a $500,000 factoring facility, immediately ...

This comprehensive report delivers insights into market trends, drivers, and forecasts, covering recent tariff developments ...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces the company will attend the 2025 EAACI Congress in Glasgow, UK, on June 13-16.

Two companies trying to develop psychedelic medicines make a merger deal as the Trump administration has expressed support ...

Shareholders in the Nasdaq-listed German company, which is backed by billionaire investor and PayPal co-founder Peter Thiel, ...

First rule of AI club. Do not talk about relying on AI unless you know your audience wants to hear it. A survey found that ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...